ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 65
    RA-Associated Antibodies Targeting Post Translational Modification Have Different Osteoclastogenetic Potential
  • Abstract Number: 2572
    Rab4a Control over Glycolytic Metabolism and T-Cell Lineage Specification Protects from Intra-Alveolar Hemorrhage in Mouse Model of SLE
  • Abstract Number: 2578
    RAB4A Protects from Antinuclear Antibody Production and Nephritis in the Pristane-Induced Model of SLE
  • Abstract Number: 2518
    Racial Differences in Clinical Characteristics and Co-Morbidities of Ankylosing Spondylitis
  • Abstract Number: 1204
    Radiographic Outcomes Were Associated with Pain and Function Responses: Post-Hoc Analysis of Results from a Phase 2 Study of a Small Molecule Wnt Pathway Inhibitor, SM04690, for Knee Osteoarthritis Treatment
  • Abstract Number: 2466
    Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Treated with SB2 or Reference Infliximab
  • Abstract Number: 626
    Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab over 52 Weeks
  • Abstract Number: 2038
    Radiological Changes Measured By MRI and High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Show Correlation with Michigan Hand Outcome Questionnaire (MHQ) in Rheumatoid Arthritis Patients
  • Abstract Number: 825
    Radiological Disease Activity Is the Major Determinant for Physicians While Deciding Active Disease in Takayasu Arteritis
  • Abstract Number: 382
    Radiological Features Identified in the Hands of Children with Down Syndrome and Inflammatory Arthritis
  • Abstract Number: 1123
    Random Urinary Uric Acid/Creatinine Ratio Is Useful in the Estimation of 24-Hour Urine Uric Acid Excretion in Patients with Gout
  • Abstract Number: 2443
    Randomized, Double-Blind, Single-Dose, Three-Arm Parallel Trial to Determine the Pharmacokinetics and Safety of GP2017, EU- and US-Adalimumab in Healthy Male Subjects
  • Abstract Number: 5L
    Rapamycin Vs. Placebo for the Treatment of Inclusion Body Myositis: Improvement of the 6 Min Walking Distance, a Functional Scale, the FVC and Muscle Quantitative MRI
  • Abstract Number: 855
    Rapid and Sustained Pain Improvement in Rheumatoid Arthritis Patients Treated with Baricitinib Compared to Adalimumab or Placebo
  • Abstract Number: 1169
    Rapid Improvement with Tocilizumab in Refractory and Severe Uveitic Cystoid Macular Edema
  • Abstract Number: 625
    Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials
  • Abstract Number: 2451
    Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
  • Abstract Number: 2054
    Rapid Tophus Resolution in Chronic Refractory Gout Patients Treated with Pegloticase
  • Abstract Number: 1813
    Rates of Contraceptive Use and Unintended Pregnancy in Teen Girls Prescribed Teratogenic Medications
  • Abstract Number: 1962
    Rates of Malignancy Associated with Anti-TNF Agents and Subsequent Biologic Use after Malignancy Using U.S. SEER Registry Data
  • Abstract Number: 838
    Rates of New-Onset Pulmonary Disease Among Patients with Systemic Lupus Erythematosus in Sweden
  • Abstract Number: 312
    Rates of Total Joint Replacement Utilization in the U.S.: Future Projections to 2020-2040 Using the National Inpatient Sample
  • Abstract Number: 424
    Re-Establishment of Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, in Rheumatoid Arthritis Patients after Temporary Discontinuation
  • Abstract Number: 344
    Real World Clinical Trial Comparing the Patient Reported Outcomes Measurement Information System Short Forms and Profiles to CDAI Disease Classification in Rheumatoid Arthritis Patients
  • Abstract Number: 206
    Real World IGRA Testing in Rheumatology Practice
  • Abstract Number: 1511
    Real-Life Performance of the ASAS Health Index in Routine Care of Patients with Spondyloarthritis
  • Abstract Number: 2673
    Real-Life Treatment Strategies for Systemic Sclerosis According to Experts
  • Abstract Number: 2454
    Real-World Consistency of Response to Adalimumab over Time in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
  • Abstract Number: 2491
    Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive Vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study
  • Abstract Number: 1543
    Real-World Effectiveness of TNF Inhibition in Spondyloarthritis. Data from a Large Nationwide Prospective Cohort – the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis
  • Abstract Number: 2258
    Real-World Evidence Linking Health-Related Quality of Life to Work Outcomes in Patients with Rheumatoid Arthritis
  • Abstract Number: 2831
    Real-World Experience with Tofacitinib Versus Adalimumab and Etanercept in Biologic-Naive Patients with RA Previously Treated with Methotrexate: Data from a US Administrative Healthcare Insurance Claims Database
  • Abstract Number: 1252
    Real-World Oral Methotrexate Adherence Measured Electronically in Patients with Established Rheumatoid Arthritis
  • Abstract Number: 1524
    Real-World Use of Secukinumab Among Biologic-NaïVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
  • Abstract Number: 1041
    Real-World Utilization of Biosimilars for Management of Rheumatoid Arthritis (RA) in the US
  • Abstract Number: 2223
    Reallocating Time Spent in Sleep, Sedentary Behavior and Physical Activity and Its Association with Pain and Depression
  • Abstract Number: 280
    Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study.
  • Abstract Number: 2791
    Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Marginal Jawbone Loss Predates the Onset of Rheumatoid Arthritis
  • Abstract Number: 21
    Reciprocal Regulation of B Cells on Bleomycin-Induced Scleroderma Model: IL-6-Producing Effector B Cells Play a Pathogenic Role, While IL-10-Producing Regulatory B Cells Play a Protective Role
  • Abstract Number: 2732
    Recommendations for the Management of Neuro-Behcet’s Disease By the Japanese National Research Committee for Behcet’s Disease
  • Abstract Number: 2395
    Recommendations on the Management of Rheumatoid Arthritis in Patients with Cancer: A Systematic Review of Clinical Practice Guidelines and Consensus Statements
  • Abstract Number: 437
    Recruitment of RA Trials in the Modern Era: Are United States-Based Trials Still Feasible?
  • Abstract Number: 653
    Reduced Ubiquitination of Misfolded HLA-B27 Is Associated with Inefficient Degradation By ERAD and Autophagy
  • Abstract Number: 1201
    Reducing Heterogeneity in OA Clinical Trials: Data from a Phase 2 Study of SM04690, a Novel, Intra-Articular, Wnt Pathway Inhibitor in Knee Osteoarthritis
  • Abstract Number: 502
    Reduction in Disease Activity in Patients with RA and an Inadequate Response to MTX: Baricitinib Compared to Adalimumab and Placebo
  • Abstract Number: 2676
    Reduction of Dlco and FVC in Patients with GERD and Systemic Sclerosis
  • Abstract Number: 2042
    Referral Criteria to an Early Arthritis Clinic: Poor Agreement between Referring Physicians and Rheumatologists
  • Abstract Number: 141
    Refractory Disease in Rheumatoid Arthritis: Results from the British Society of Rheumatology Biologics Register for Rheumatoid Arthritis
  • Abstract Number: 423
    Refractory Pain in Spite of Inflammation Control after Start of Anti-TNF Therapy in RA: Observational Data from Southern Sweden
  • Abstract Number: 905
    Regenerating Cartilage and Reversing Osteoarthritis (OA) Stimulation of Adenosine A2A Receptors (A2AR) Increases Cartilage Volume and Matrix in Vitro and In Vivo
  • Abstract Number: 2684
    Regional and Whole Gut Transit Times in Patients with Systemic Sclerosis Using the Wireless Motility Capsule
  • Abstract Number: 2790
    Regulation of ASK1 Expression and Its Role in Rheumatoid Arthritis (RA)
  • Abstract Number: 86
    Regulation of Interleukin-1β Signaling By Inhibition of O-Glc-Nacase in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 73
    Regulation of Th17 Cell Responses By IL-25
  • Abstract Number: 43
    Regulation of TLR7 Signalling By UBE2L3 Dependent Linear Ubiquitination Explains Dimethyl Fumarate Suppression of Autoreactive B Cell Development in SLE
  • Abstract Number: 2185
    Relation of Foot Pronation to Medial Knee Load in Persons with Medial Knee Osteoarthritis
  • Abstract Number: 2184
    Relation of Gait Speed to Incident Knee Replacement: The Multicenter Osteoarthritis Study
  • Abstract Number: 1464
    Relation of HLA-DRB1 Genotype to the Efficacies of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis
  • Abstract Number: 1212
    Relation of Incident Bisphosphonate Use to Bone Marrow Lesion Volume in Knee Osteoarthritis
  • Abstract Number: 857
    Relation of Pain Sensitization to Low Physical Function: The Multicenter Osteoarthritis Study
  • Abstract Number: 2063
    Relation of Serum Urate and Gout Duration to Tophi, Urate Deposition, and Inflammation
  • Abstract Number: 2085
    Relationship between Gout and Asthma: A National Database Analysis
  • Abstract Number: 306
    Relationship between Inflammatory Anterior or Posterior Arch MRI Abnormalities and Clinical Data in Low Back Pain Patients
  • Abstract Number: 1979
    Relationship between Religiosity /Spirituality and Physical and Mental Outcomes in Fibromyalgia Patients
  • Abstract Number: 1358
    Relationship between Serum Protein Pattern and High Disease Activity in Patients with Rheumatoid Arthritis
  • Abstract Number: 123
    Relationship between Shift Work and the Onset of Rheumatoid Arthritis; Results from a Swedish Case-Control Study
  • Abstract Number: 2369
    Relationship of Bone Mineral Density and Inflammatory Burden with Carotid Plaque Formation in Rheumatoid Arthritis: A 5-Year Prospective Study
  • Abstract Number: 926
    Relationship of Traumatic Knee Injuries to Early-Onset Knee Osteoarthritis in Young Military Officers
  • Abstract Number: 2693
    Relationships between Levels of Patient Activation, Self-Efficacy, and Demographic Variables in Systemic Sclerosis
  • Abstract Number: 1263
    Relevance and Utility of Patient Reported Outcomes Measurement Information System (PROMIS®) Instruments in SLE: A Qualitative Study
  • Abstract Number: 2014
    Reliability of 8-Joint Ultrasonography Scores in Follow up of Biological Therapy in Patients with Rheumatoid Arthritis
  • Abstract Number: 265
    Reliability of an Omeract Semiquantitative Scoring System and Imaging Atlas for the Assessment of Cartilage in Hand Osteoarthritis
  • Abstract Number: 2382
    Reliability of the Biochemical Bone Markers CTX and P1NP during a TNF-Inhibitor Treatment Cycle in Patients with Rheumatoid Arthritis
  • Abstract Number: 2021
    Reliability of Ultrasound Elementary Lesions in Gout: Results from an Inter- and Intra-Reading International Multicenter Exercise By 62 Sonographers
  • Abstract Number: 385
    Reliable Implementation of a Hepatitis B Serology Screening and Vaccination Process for Immunocompromised Pediatric Rheumatology Patients
  • Abstract Number: 2219
    Remaining Pain in DMARD-Naive Rheumatoid Arthritis Patients Treated with Baricitinib and Methotrexate
  • Abstract Number: 1042
    Remote Management of Osteoporosis Screening and Treatment in US Veterans Using a Bone Health Team: A Cost-Effectiveness Analysis
  • Abstract Number: 1288
    Renal Disease Course in Pediatric Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis in the First 12-Months – a Pediatric Vasculitis Initiative (PedVas) Study
  • Abstract Number: 9
    Renal Protective Effect of Antiplatelet Therapy in Antiphospholipid Antibody-Positive Lupus Nephritis Patients without the Antiphospholipid Syndrome
  • Abstract Number: 429
    Repair of Joint Damage Is Rare in Newly Diagnosed Rheumatoid Arthritis Patients and Appears Not to Relate to Previous Suppression of Inflammation
  • Abstract Number: 496
    Repeated Rituximab Infusions for the Therapy of Rheumatoid Arthritis Is Not Associated with Increased Rates of Serious Infections
  • Abstract Number: 1127
    Replication of Genetic Association of Peroxisome Proliferator-Activated Receptor Gamma-1B with Gout in a New Zealand Polynesian Sample Set
  • Abstract Number: 1945
    Repositioning Suramin As a Cartilage-Protective Drug
  • Abstract Number: 2743
    Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN)
  • Abstract Number: 1559
    Residual Disease Activity in Psoriatic Arthritis Triggers Treatment Adjustment in Only a Quarter of Patients in Daily Clinical Practice
  • Abstract Number: 2996
    Resilience and Transition Readiness in Pediatric SLE Patients
  • Abstract Number: 1586
    Resistant Hypertension Is Associated with Inflammation, Renal Function, and Increased Mortality in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 61
    Resolution of Systemic Joint Inflammatory Processes and Regeneration of Existing Bone Damage upon TNF Blockade As Monitored By In Vivo Multimodal PET-CT Imaging in Progressed Experimental Arthritis
  • Abstract Number: 2640
    Response Gene to Complement-32 Expression Is Upregulated in Lupus T Cells and Promotes IL-17A Expression
  • Abstract Number: 498
    Response to Abatacept of Different Patterns of Interstitial Lung Disease in Rheumatoid Arthritis. Multicenter Study of 63 Patients
  • Abstract Number: 2758
    Response to JAK1/2 Inhibition with Baricitinib in “Candle”, “Savi” and “Candle-like” Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases
  • Abstract Number: 1184
    Response to Methotrexate and Glucocorticoid Injection in New Onset Arthritis after Checkpoint Inhibitor Therapy
  • Abstract Number: 1082
    Responsiveness and Minimally Clinically Important Differences of Promis Measures in Rheumatoid Arthritis
  • Abstract Number: 1264
    Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests (CATs) in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 2951
    Responsiveness of the Patient Reported Outcomes Measurement Information System to Golimumab Intravenous and Infliximab Treatment in a Real World Clinical Trial in Rheumatoid Arthritis Patients
  • Abstract Number: 2668
    Responsiveness of University of California Los Angeles Scleroderma Clinical Trial Consortium (GIT2.0) and Intestinal Visual Analogue Scale to Change in Systemic Sclerosis Patients
  • Abstract Number: 935
    Results from a 52 Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for the Treatment of Knee Osteoarthritis
  • Abstract Number: 42
    Resveratrol Regulates Sirt1 to Control B Cells Activation and Plasma B Cells Differentiation
  • Abstract Number: 2478
    Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras – Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®
  • Abstract Number: 2357
    Retinal Vessel Morphological Associations with Systemic Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
  • Abstract Number: 1330
    Rhesus Theta Defensin 1 (RTD-1) Suppresses Disease-Associated Genes and Induces Anti-Inflammatory Expression Signature in Synovial Tissues of Rat Model of Rheumatoid Arthritis
  • Abstract Number: 277
    Rheumatic Conditions Appearing De Novo after Infection with Chikungunya Virus in Venezuelan Patients
  • Abstract Number: 1173
    Rheumatic Immune Related Adverse Events Due to Programmed Cell Death Protein 1 (PD-1) Inhibition for Cancer: Comprehensive Analysis of a Whole Cancer Cohort
  • Abstract Number: 1156
    Rheumatic Immune Related Adverse Events from Checkpoint Inhibitor Therapy for Cancer: Long-Term Follow up Data
  • Abstract Number: 1153
    Rheumatic Manifestations of Whim Syndrome
  • Abstract Number: 2422
    Rheumatoid Arthritis (RA) Synovial Fluid Treg Cells Secrete IL-17 and at the Same Time Are Potent Suppressors of Tresp Cell Proliferation, TNF-α and Interferon γ Production
  • Abstract Number: 837
    Rheumatoid Arthritis and Risk for Chronic Obstructive Pulmonary Disease or Asthma Among Women during 38 Years of Prospective Follow-up
  • Abstract Number: 137
    Rheumatoid Arthritis and the Risk for Interstitial Lung Disease: A Comparison of Risk Associated with Biologic and Conventional Dmards
  • Abstract Number: 2399
    Rheumatoid Arthritis Have Lower Glomerular Filtration Rate Compared to Healthy Population: Role of Inflammation
  • Abstract Number: 244
    Rheumatoid Arthritis Imaging on PET-CT Using a Novel Folate Receptor Ligand for Macrophage Targeting
  • Abstract Number: 475
    Rheumatoid Arthritis Patient Characteristics Also Predict Response to Therapy with Biologic Agents: Results from the Corrona Certain Study
  • Abstract Number: 440
    Rheumatoid Arthritis Patient´s Journey: Delay in Diagnosis and Treatment
  • Abstract Number: 1083
    Rheumatoid Arthritis Patients Achieved Better Quality of Life Than Systemic Lupus Erythematosus Patients at Sustained Remission: The Impact of Disease Diagnosis on Health-Related Quality of Life Outcomes
  • Abstract Number: 471
    Rheumatoid Arthritis Patients Resistant to Biologic Therapy, Are They Different?
  • Abstract Number: 165
    Rheumatoid Arthritis Risk Polymorphisms in CCR6, SNP and Estrogen-Dependent Response to Immune Mediator Gene Expression, and NF-κb Transcriptional Activity: Crosstalk between the Immune and Endocrine Systems
  • Abstract Number: 2401
    Rheumatoid Arthritis with Kidney Dysfunction Contributes to Higher Risk of Cardiovascular Disease Development
  • Abstract Number: 2741
    Rheumatoid Factor (RF) Levels Remain Persistently Elevated 24 Weeks after Interferon (INF) Free Direct Antiviral Agents (DAA) Therapy in the Majority of RF+ HCV Infected Persons
  • Abstract Number: 2119
    Rheumatological Immune Related Adverse Events in Malignancy Patients Treated with Anti-Programmed Cell Death (PD) 1 Antibodies
  • Abstract Number: 2498
    Rheumatologists Use Different Cut-Offs for Disease Activity in Real Life – the Experience with Golimumab in Ankylosing Spondylitis- Subanalysis from a Non-Interventional German Study
  • Abstract Number: 2036
    Rheumatologists’ Compliance with Screening for Viral Hepatitis B and C Prior to Initiation of Methotrexate Treatment Needs Quality Improvement
  • Abstract Number: 1087
    Rheumatology Clinic Smoking Cessation Protocol Markedly Increases Quit Line Referrals
  • Abstract Number: 106
    Rheumatology Fellows Teaching in a Consult Setting: Pilot Project at Two Training Hospitals
  • Abstract Number: 101
    Rime (Reporter-Interpreter-Moderator-Educator) Evaluation Tool to Assess Fellows in Rheumatology
  • Abstract Number: 1279
    Risk Factors for Achieving a Drug-Free Remission in Patients with Juvenile Dermatomyositis
  • Abstract Number: 2309
    Risk Factors for Arthritis and the Development of Comorbid Cardiovascular and Metabolic Disease in Children with Psoriasis
  • Abstract Number: 317
    Risk Factors for Blood Transfusions Following Total Joint Arthroplasty in Patients with Rheumatoid Arthritis
  • Abstract Number: 1268
    Risk Factors for Bone Loss in Juvenile-Onset Systemic Lupus Erythematosus: A Prospective Study
  • Abstract Number: 1618
    Risk Factors for Development of Early Infectious and Non-Infectious Complications in Systemic Lupus Erythematosus Patients Undergoing Major Surgery
  • Abstract Number: 1961
    Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study
  • Abstract Number: 717
    Risk Factors for Neuropsychiatric Systemic Lupus Erythematosus and Its Recurrence
  • Abstract Number: 1750
    Risk of Cardiovascular and Thrombotic Disease Among Patients with Incident ANCA-Associated Vasculitis: A 20 Year Population Based Cohort Study
  • Abstract Number: 2844
    Risk of Cardiovascular Events in Older Patients with Gout Initiating Febuxostat Versus Allopurinol: A Population-Based Cohort Study
  • Abstract Number: 1113
    Risk of Cardiovascular Events in Older Patients with Gout Initiating Probenecid Versus Allopurinol: A Population-Based Cohort Study
  • Abstract Number: 1691
    Risk of Development of Definite Disease in Patients with Early Systemic Sclerosis
  • Abstract Number: 2188
    Risk of Disability in Underweight Persons with or at Increased Risk of Knee Osteoarthritis
  • Abstract Number: 1035
    Risk of Hospitalization Among RA Patients with Multiple Autoimmune Co-Morbidities Differs By DMARD Treatment
  • Abstract Number: 2752
    Risk of Hospitalizations for Venous Thromboembolism Among Patients with Selected Systemic Vasculitides: A Nationwide Analysis
  • Abstract Number: 1481
    Risk of Ischemic Heart Disease in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis of Observational Studies
  • Abstract Number: 1480
    Risk of Ischemic Stroke in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis
  • Abstract Number: 2972
    Risk of Myocardial Infarction and Cerebrovascular Accident in Ankylosing Spondylitis: A General Population-Based Study
  • Abstract Number: 1316
    Risk of Preterm Delivery Associated with Perinatal Exposure to Dmards in Women with Inflammatory Arthritis: A Population-Based Cohort Study
  • Abstract Number: 11L
    Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study
  • Abstract Number: 2274
    Risk of Serious Events, Serious Infections, Uveitis, Crohn’s Disease, Colitis and Malignancies in Patients with Juvenile Idiopathic Arthritis on Continuous Treatment with Etanercept over Time: A Report from a Biologics Registry
  • Abstract Number: 1758
    Risk of Serious Infection in Granulomatosis with Polyangiitis or Microscopic Polyangiitis: Long-Term Outcomes of 126 Wegent Trial Patients
  • Abstract Number: 842
    Risk of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologic Vs. Non-Biologic Dmards
  • Abstract Number: 1966
    Risk of Tuberculosis in Biologic Users for Rheumatic Diseases: Results from the South African Biologics Registry
  • Abstract Number: 819
    Risks of Non-Cardiovascular Corticosteroid Related Adverse Events and Cancer in Giant Cell Arteritis: A  French Population-Based Cohort Study
  • Abstract Number: 18L
    Rituximab As Re-Induction Therapy in Relapsing ANCA-Associated Vasculitis
  • Abstract Number: 1175
    Rituximab for Idiopathic and IgG4-Related Retroperitoneal Fibrosis
  • Abstract Number: 1757
    Rituximab for Induction and Maintenance Therapy of Granulomatosis with Polyangiitis: A Single-Center Cohort Study on 114 Patients
  • Abstract Number: 2402
    Rituximab in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicenter Study of 32 Patients
  • Abstract Number: 2486
    Rituximab Is an Attractive Proposition to Treat Difficult Active RA in Indian (Asia) Patients: Initial Results of a Non Commercial Initiative Using an Initial Regimen of Two 500 Mg Infusions (fortnightly) and a Third 500 Mg Infusion at 6 Weeks in Case of Inadequate Response(ACR 50)
  • Abstract Number: 2461
    Rituximab Is Effective in the Treatment of Rheumatoid Arthritis Irrespective of Body Mass Index; Up to 48 Weeks Results from Phase 3 Study
  • Abstract Number: 852
    RNAseq Detection of Gene Dysregulation in PBMCs from Juvenile Dermatomyositis, Positive for p155/140 Myositis Specific Antibody
  • Abstract Number: 941
    Ro/SSA Autoantibody Exposed Neonates Have an Expansion of NK Cells and a Discernible Type II IFN Signature with High IFNγ in Peripheral Blood
  • Abstract Number: 2579
    Rock-Mediated Pkca Nuclear Translocation Is Important in Neutrophil Netosis and UVB Induced-Skin Inflammation
  • Abstract Number: 1585
    Role of Corticosteroids in Subclinical Atherosclerosis in SLE: A Systematic Review and Meta-Analysis
  • Abstract Number: 649
    Role of Eicosanoids As Biomarkers in Psoriatic Arthritis
  • Abstract Number: 901
    Role of Epstein Barr Virus Serologic Reactivation in Transitioning to Systemic Lupus Erythematosus in at Risk Individuals
  • Abstract Number: 1339
    Role of Hexokinase-2 in Synovial Lining Hypertrophy in Murine Arthritis
  • Abstract Number: 651
    Role of Mir-21-5p As a Potential Biomarker of Psoriatic Arthritis and Response to Treatment
  • Abstract Number: 1642
    Role of Plaque in Predicting Cardiovascular Events in Women with Lupus over a 20 Year Followup
  • Abstract Number: 962
    Role of Syndecans in Cytokine Mediated Inflammation in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 942
    Role of the Pyrin Inflammasome in Resistance to Yersinia Pestis: A Possible Selective Advantage for Carriers of MEFV Mutations
  • Abstract Number: 752
    Role of the Six-Minute Walk Test in Systemic Sclerosis: Five Years Evolution
  • Abstract Number: 1582
    RORγt Inhibition Selectively Targets Pathogenic Subsets of Human iNKT and γδ-T Cells Enriched in Spondyloarthritis While Preserving Tissue Protective IL-22 Responses
  • Abstract Number: 2079
    Rotator Cuff Calcific Tendinopathy: Chondrocyte-like Cells Surrounding Calcific Deposits Express TNAP and ENPP1, Two Key Enzymes of the Mineralization Process.
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences